// App-Quantinova.ai

: OVER-EXPRESSION OF CRLF2 BY FLOW CYTOMETRY (FC) AND DEFINED BY RATIO B, IMPACTS ON DISEASE-FREE SURVIVAL (DFS) IN MEXICAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL).

Researchers

Presenter

  • Emmanuel Almanza Huante

Principal Investigators

  • Roberta Demichelis Gomez

  • Eunice Rojas Zaldivar

  • Alexia Andrade Mondaca

  • Areli Eunice Hernndez Alcntara

  • Alfredo Pinedo

  • Emmanuel Fernndez Snchez

  • Gabriela Nora Cesarman Maus

  • Karla Adriana Espinosa Bautista

Medical Centers

  • Hematology, Instituto Nacional de Cancerologia, Mexico city, Mexico

  • Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico

  • Unidad de Diagnóstico y Soporte Hematológico,Instituto Nacional de Cancerología,Mexico City,Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A